Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,444,122
-
Total 13F shares
-
43,396,946
-
Share change
-
+138,409
-
Total reported value
-
$623,274,490
-
Put/Call ratio
-
377%
-
Price per share
-
$14.33
-
Number of holders
-
275
-
Value change
-
-$6,741,914
-
Number of buys
-
126
-
Number of sells
-
108
Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q1 2025
As of 31 Mar 2025,
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) was held by
275 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,396,946 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., DIMENSIONAL FUND ADVISORS LP, ARMISTICE CAPITAL, LLC, BROWN ADVISORY INC, STATE STREET CORP, Paradice Investment Management LLC, D. E. Shaw & Co., Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
275
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.